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Abstract: A minor byproduct in the reaction of (S)-prolinol with thiophosgene in the presence of
triethylamine is identified as a novel tricyclic dipyrrolidino-1,3,6-oxadiazocane-2-thione, the first
example of such a ring system, and a representative of the uncommon, but useful 1,3,6-oxadiazocanes.
A mechanism is proposed for its formation.
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1. Introduction
Some years ago we reported synthesis of the simple bicyclic 1,3-oxazolidine-2-thione 1 by
reaction of (S)-prolinol with thiophosgene in the presence of triethylamine and its conversion into
chiral iminium salts useful for the kinetic resolution of alkoxides [1]. The same compound was
reported again recently and was shown to be converted by a ruthenium catalyst into the isomeric
1,3-thiazolidin-2-one [2], also mentioned in our earlier publication [1]. We now describe the isolation
and identification of a minor byproduct in the synthesis of 1, which has the novel tricyclic structure 2
featuring a central 1,3,6-oxadiazocane ring.
2. Results
The synthesis of 1 involved slow addition of thiophosgene to a mixture of prolinol and two
equivalents of triethylamine in CH2Cl2 at 0 ◦C (Scheme 1). Chromatographic purification on alumina
gave the main product in analytically pure form and moderate yield as fine colourless crystals [1].
In their more recent work, Frost and co-workers conducted the reaction in CHCl3 at room temperature
and obtained 1 in high yield by trituration [2] with a good match in spectroscopic properties. However,
in the course of repeated chromatographic purifications we noticed a minor product at much higher Rf
which was isolated in 1% yield and for which we propose the structure 2 containing the previously
unknown 1,3,6-oxadiazocane-2-thione ring system. The 1H-NMR spectrum contained signals for 18
hydrogens, clearly indicating that two inequivalent prolinol-derived fragments were present and this
was confirmed by the 13C-NMR spectrum with 11 signals including one C=S at 191 ppm, one CH2O at
79 ppm, two CHNs at 60–65 ppm, three CH2N signals in the range 50–60 ppm and four CH2 signals
remote from a heteroatom at 20–30 ppm. Particularly the presence of a third CH2N signal together
with only one CH2O and a correct high-resolution mass spectrometry measurement leave little doubt
as to the structure of 2. By means of COSY and HSQC NMR studies an almost complete assignment of
NMR signals was possible (Figure 1, Table 1).
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Scheme 1. Synthetic route to 1 and 2. 
 
Figure 1. Numbering system for 2. 
Table 1. NMR assignment for 2. 
δC mult. (DEPT) δH (HSQC) Coupled H (COSY) Assignment 
190.5 C —  5-C=S 
78.9 CH2 4.08, 4.16  7-CH2O 
62.6 CH 3.10 4.08 7a-CHN 
60.0 CH 4.55 2.53, 2.08 12a-CHN 
58.3 CH2 2.53 (2H)  12-CH2N 
56.7 CH2 3.10, 2.56  10-CH2N 
50.1 CH2 3.80, 3.66 2.08 3-CH2N 
28.6 CH2 †  1-CH2 * 
27.2 CH2 †  8-CH2 * 
24.4 CH2 †  2-CH2 * 
22.4 CH2 †  9-CH2 * 
* Assignments may be interchanged, † 2.10, 2.05 (2H), 1.85, 1.75 (2H), 1.70, 1.45—assignment 
uncertain due to peak overlap. 
Although it is only formed in low yield, this product is the first 1,3,6-oxadiazocane-2-thione as 
far as we are aware. Indeed a literature search shows very few publications dealing with 
1,3,6-oxadiazocine rings in any state of unsaturation or oxidation. A summary of all such related 
structures, many of which show potentially useful properties, is shown in Figure 2. NMR studies on 
the conformation of bicyclic oxadiazocane 3 [3] and oxadiazocanone 5 [4] have appeared and the 
ditosyl oxadiazocane 4 was obtained as a byproduct in azamacrocycle synthesis [5]. The bridged 
oxadiazocanones 6 were investigated as potential central nervous system-active agents [6], and the 
benzoxadiazocinone system 7 was obtained by the photochemical rearrangement of a 
benzodiazepinone [7]. The unsaturated benzoxadiazocine 8 was prepared as a novel heterocycle [8], 
and reaction of two equivalents of 2H-azirines with chlorosulfonyl isocyanate gives the 
oxadiazocinones 9 [9]. Various ring-fused derivatives are also known including the purine-fused 
compounds 10 [10], and the imidazo[2,1-b] fused compounds 11 which are active against 
tuberculosis and a range of other tropical diseases [11,12]. Compound 12 is formed as a byproduct in 
a Pictet Spengler reaction [13]. A range of amino acid-derived oxadiazocanetriones 13 are useful as a 
component of gel electrolytes [14], and amino acid-derived oxadiazocanediones 14 are active as 
phospholipase A2 inhibitors [15,16] and against malaria and AIDS [17,18]. Finally, mention could be 
made of the closely related 1,3,6-thiadiazocane-2-thione, the only similar system as far as we are 
aware containing a thione [19]. 
Scheme 1. Synthetic route to 1 and 2.
Molbank 2018, 2018, M9xx FOR PEER REVIEW  2 of 5 
 
Scheme 1. Synthetic route to 1 and 2. 
 
Figure 1. Numbering system for 2. 
Table 1. NMR assignment for 2. 
δC mult. (DEPT) δH (HSQC) Coupled H (COSY) Assignment 
190.5 C —  5-C=S 
78.9 CH2 4.08, 4.16  7-CH2O 
62.6 CH 3.10 4.08 7a-CHN 
60.0 CH 4.55 2.53, 2.08 12a-CHN 
58.3 CH2 2.53 (2H)  12-CH2N 
56.7 CH2 3.10, 2.56  10-CH2N 
50.1 CH2 3.80, 3.66 2.08 3-CH2N 
28.6 CH2 †  1-CH2 * 
27.2 CH2 †  8-CH2 * 
24.4 CH2 †  2-CH2 * 
22.4 CH2 †  9-CH2 * 
* Assignments may be interchanged, † 2.10, 2.05 (2H), 1.85, 1.75 (2H), 1.70, 1.45—assignment 
uncertain due to peak overlap. 
Although it is only formed in low yield, this product is the first 1,3,6-oxadiazocane-2-thione as 
far as we are aware. Indeed a literature search shows very few publications dealing with 
1,3,6-oxadiazocine rings in any state of unsaturation or oxidation. A summary of all such related 
structures, many of which show potentially useful properties, is shown in Figure 2. NMR studies on 
the conformation of bicyclic oxadiazocane 3 [3] and oxadiazocanone 5 [4] have appeared and the 
ditosyl oxadiazocane 4 was obtained as a byproduct in azamacrocycle synthesis [5]. The bridged 
oxadiazocanones 6 were investigated as potential central nervous system-active agents [6], and the 
benzoxadiazocinone system 7 was obtained by the photochemical rearrangement of a 
benzodiazepinone [7]. The unsaturated benzoxadiazocine 8 was prepared as a novel heterocycle [8], 
and reaction of two equivalents of 2H-azirines with chlorosulfonyl isocyanate gives the 
oxadiazocinones 9 [9]. Various ring-fused derivatives are also known including the purine-fused 
compounds 10 [10], and the imidazo[2,1-b] fused compounds 11 which are active against 
tuberculosis and a range of other tropical diseases [11,12]. Compound 12 is formed as a byproduct in 
a Pictet Spengler reaction [13]. A range of amino acid-derived oxadiazocanetriones 13 are useful as a 
component of gel electrolytes [14], and amino acid-derived oxadiazocanediones 14 are active as 
phospholipase A2 inhibitors [15,16] and against malaria and AIDS [17,18]. Finally, mention could be 
made of the closely related 1,3,6-thiadiazocane-2-thione, the only similar system as far as we are 
aware containing a thione [19]. 
i re 1. eri s ste f r 2.
Table 1. R assign ent for 2.
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Although it is only formed in low yield, this product is the first 1,3,6-oxadiazocane-2-thione as far
as we are aware. Indeed a literature search shows very few publications dealing with 1,3,6-oxadiazocine
rings in any state of unsaturation or oxidation. A summary of all such related structures, many of
which show potentially useful properties, is shown in Figure 2. NMR studies on the conformation
of bicyclic oxadiazocane 3 [3] and oxadiazocanone 5 [4] have appeared and the ditosyl oxadiazocane
4 was obtained as a byproduct in azamacrocycle synthesis [5]. The bridged oxadiazocanones 6 were
investigated as potential central nervous system-active agents [6], and the benzoxadiazocinone system
7 was obtained by the photochemical rearrangement of a benzodiazepinone [7]. The unsaturated
benzoxa iazocine 8 was prepared as a novel heterocycle [8], and reaction of two equivalents of
2H-azirines with chlorosulfonyl isocyanate gives the oxadiazocinones 9 [9]. Various ring-fused
derivatives are also known including the purine-fused compounds 10 [10], and the imidazo[2,1-b]
fused compounds 11 which are active against tuberculosis and a range of other tropical
diseases [11,12]. Compound 12 is formed as a bypro uct in a Pictet Spengler reaction [13]. A range
of amino acid- erived oxadiazocanetriones 13 are useful as a component of gel electrolytes [14],
and amino acid-derived oxadiazocanediones 14 are acti e as phospholipase A2 inhibitors [15,16]
and agai st malaria and AIDS [17,18]. Finally, mention could be made of the closely related
1,3,6-t iadiazocane-2-thione, the only similar system as far as we are aware containing a thione [19].
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The likely mechanism for formation of 2 is shown in Scheme 2. Initial reaction of prolinol with 
one molecule of thiophosgene and base gives the thiocarbamoyl chloride 16 and, if this simply loses 
HCl intramolecularly, the major product 1 is formed. If this intermediate is instead attacked 
intermolecularly by a second molecule of proline, the thiocarbamate 17 is formed containing a free 
CH2OH group. This can combine with a second molecule of thiophosgene to give the 
chlorothioformate 18 and this then undergoes intramolecular attack of the pyrrolidine nitrogen with 
loss of COS to afford the observed product 2. 
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3. Experimental Section 
Octahydro-1H,5H,7H-dipyrrolo[1,2-c:1′,2′-f][1,3,6]oxadiazocine-5-thione (2) 
A solution of (S)-prolinol [20] (5.0 g, 50 mmol) and triethylamine (14.0 mL, 10.12 g, 100 mmol) in 
CH2Cl2 (250 mL) was stirred at 0 °C while a solution of thiophosgene (5.03 mL, 7.59 g, 66 mmol) in 
CH2Cl2 (100 mL) was added dropwise. The solution was then allowed to warm up to room 
temperature and stirred for 16 h. The solution was washed with water (2 × 250 mL) and 0.5 M aq. 
sodium hydroxide (200 mL) and then dried and evaporated to afford a dark coloured oil (6.49 g). 
Figure 2. Related 1,3,6-oxadiazocine ring syste s.
The likely mechanism for formation of 2 is shown in Scheme 2. Initial reaction of prolinol with one
molecule of thiophosgene and base gives the thiocarbamoyl chloride 16 and, if this simply loses HCl
intramolecularly, the major product 1 is formed. If this intermediate is instead attacked intermolecularly
by a second molecule of proline, the thiocarbamate 17 is formed containing a free CH2OH group.
This can combine with a second molecule of thiophosgene to give the chlorothioformate 18 and
this then undergoes intramolecular attack of the pyrrolidine nitrogen with loss of COS to afford the
observed product 2.
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3. Experimental Section
ctahydro-1 ,5 ,7 -dipyrrolo[1,2-c:1′,2′-f][1,3,6]oxadiazocine-5-thione (2)
solution of (S)-prolinol [20] (5.0 g, 50 ol) and triethyla ine (14.0 L, 10.12 g, 100 ol) in
2 l2 (250 L) as stirred at 0 ◦ hile a solution of thiophosgene (5.03 L, 7.59 g, 66 ol) in
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CH2Cl2 (100 mL) was added dropwise. The solution was then allowed to warm up to room temperature
and stirred for 16 h. The solution was washed with water (2× 250 mL) and 0.5 M aq. sodium hydroxide
(200 mL) and then dried and evaporated to afford a dark coloured oil (6.49 g). This was subjected to
column chromatography on alumina (diethyl ether/petroleum, 70:30) to give as the main product
at Rf 0.28 (S)-tetrahydro-1H,3H-pyrrolo[1,2-c]oxazole-3-thione 1 (3.11 g, 43%) as colourless crystals,
m.p. 58–59 ◦C. [α]20D + 69 (c = 1.02, CH2Cl2) (lit. [2] +55.3); 1H-NMR (300 MHz, CDCl3): δ 4.80–4.70
(m, 1H), 4.35–4.20 (m, 2H), 3.95–3.75 (m, 1H), 3.55–3.40 (m, 1H), 2.35–2.00 (m, 3H), 1.85–1.55 (m, 1H)
(good agreement with lit. [2]); 13C-NMR (75 MHz, CDCl3): δ 189.5 (C=S), 73.2 (CH2), 63.1 (CH),
47.5 (CH2), 30.8 (CH2), 26.6 (CH2) (good agreement with lit. [2]). Anal. Calcd. for C6H9NOS: C, 50.32;
H, 6.34; N, 9.78. Found: C, 50.54; H, 6.36; N, 9.79.
However, this was preceded by a minor component at Rf 0.64, obtained as a pale yellow oil,
which proved to be the title compound 2 (56.5 mg, 1%). 1H-NMR (300 MHz, CDCl3): δ 4.60–4.50
(m, 1H), 4.16 (half AB pattern of d, J 12, 5, 1H), 4.08 (half AB pattern of d, J 12, 12, 1H), 3.85–3.75 (m, 1H),
3.72–3.60 (m, 1H), 3.10–2.98 (m, 2H), 2.58–2.54 (m, 1H), 2.53 (d, J 12, 2H), 2.12–2.00 (m, 3H), 1.95–1.65
(m, 4H), 1.48–1.40 (m, 1H); 13C-NMR (75 MHz, CDCl3): δ 190.6 (C=S), 78.9 (CH2O), 62.6 (CHN),
60.0 (CHN), 58.3 (CH2N), 56.7 (CH2N), 50.1 (CH2N), 28.6 (CH2), 27.2 (CH2), 24.4 (CH2), 22.4 (CH2);
MS (EI): m/z 226 (M+, 100%), 193 (28), 163 (16), 149 (12), 110 (32), 97 (73), 82 (38), 69 (58), 55 (48).
HRMS Calcd. for C11H18N2OS: 226.1140. Found: 226.1142.
Supplementary Materials: The following are available online: http://www.mdpi.com/1422-8599/2018//M993/
s1, Figure S1: 300 MHz 1H-NMR spectrum of 2 in CDCl3, Figure S2: 75 MHz normal and DEPT 13C-NMR spectra
of 2 in CDCl3, Figure S3: COSY 2D H-H correlation NMR spectrum of 2, Figure S4: HSQC 2D C-H correlation
NMR spectrum of 2, Figure S5: Mass spectrum for 2.
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